コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 luding HTLV-1-associated myelopathy/tropical spastic paraparesis.
2 f 4 patients with HTLV-II seropositivity and spastic paraparesis.
3 own as HTLV-1-associated myelopathy/tropical spastic paraparesis.
4 ma and HTLV-1 associated-myelopathy/tropical spastic paraparesis.
5 result in debilitating leukodystrophies and spastic paraparesis.
6 ia and HTLV-1-associated myelopathy/tropical spastic paraparesis.
7 ma and HTLV-1-associated myelopathy/tropical spastic paraparesis.
8 ia and HTLV-I-associated myelopathy/tropical spastic paraparesis.
9 ia and HTLV-1-associated myelopathy/tropical spastic paraparesis.
10 sease, HTLV-I-associated myelopathy/tropical spastic paraparesis.
11 virus type I-associated myelopathy/tropical spastic paraparesis.
12 tive motor neuron disorders characterized by spastic paraparesis.
13 virus type I-associated myelopathy/tropical spastic paraparesis.
14 virus type I-associated myelopathy/tropical spastic paraparesis.
15 progressive gait ataxia with a superimposed spastic paraparesis.
16 in three, with limb and gait ataxia and mild spastic paraparesis.
17 amilies affected by Alzheimer's disease with spastic paraparesis.
18 own as HTLV-I-associated myelopathy/tropical spastic paraparesis.
19 in Reep1 null mice in addition to prominent spastic paraparesis.
20 L) and HTLV-1-associated myelopathy/tropical spastic paraparesis.
21 emia and HTLV-I-associated myopathy/tropical spastic paraparesis.
22 ementia which is, in most cases, preceded by spastic paraparesis.
23 the pathology of HTLV-1-associated/tropical spastic paraparesis.
24 ma and HTLV-1-associated myelopathy-tropical spastic paraparesis.
25 und in HTLV-I-associated myelopathy/tropical spastic paraparesis.
26 d with HTLV-1-associated myelopathy/tropical spastic paraparesis?
27 is mutated, patients frequently present with spastic paraparesis, a thin corpus callosum, and cogniti
28 kemia virus-1-associated myelopathy/tropical spastic paraparesis, A6 also recognizes a self peptide f
31 ed with a similar combination of progressive spastic paraparesis and polyneuropathy, variably associa
33 M/TSP (HTLV-I-associated myelopathy/tropical spastic paraparesis), by reducing the proviral load of H
34 (CNS), HTLV-I-associated myelopathy/tropical spastic paraparesis, characterized pathologically by inf
35 of childhood disease onset, ID, progressive spastic paraparesis, dysarthria, dysmorphisms, and white
36 isease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and adult T cell leukemia/
37 rosis, HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) and chronic Lyme neuroborr
38 pe 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and multiple sclerosis (MS
39 us 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and multiple sclerosis (MS
40 pe I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) are known to be caused by
41 (HTLV) type I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) based on newly developed m
42 pe I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) exhibit reduced Foxp3 expr
43 ated (HTLV-I-associated) myelopathy/tropical spastic paraparesis (HAM/TSP) has been shown to be a maj
44 pe 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic neurological
45 pe I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic, progressive
46 pe I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a neurological disease
47 pe 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a progressive inflammat
48 pe I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an immune-mediated infl
49 pe I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an inflammatory neurolo
50 pe I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an inflammatory neurolo
51 pe I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is associated with immunor
53 ATLL) or HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) or develop a plethora of o
54 pe I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) proliferate spontaneously
55 s with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) results in a decrease in F
56 ent of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), a chronic inflammatory di
57 pe 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP), a disease that can be ind
58 L) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), a progressive neurodegene
59 evelop HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), an immune-mediated disord
60 s with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), mono- or oligoclonal expa
61 ent of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), observed in up to 5% of i
62 ing in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), or adult T cell leukemia/
80 sease (HTLV-I-associated myelopathy/tropical spastic paraparesis [HAM/TSP]) is suggested to be an imm
81 virus type I-associated myelopathy/tropical spastic paraparesis has been reported and is thought to
83 alleles found in ex vivo samples of tropical spastic paraparesis-HTLV-1-associated myelopathy patient
84 segregation of different alleles in tropical spastic paraparesis-HTLV-associated myelopathy and ATLL
85 and the neurodegenerative disorder tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HA
86 adult T-cell leukemia/lymphoma and tropical spastic paraparesis/HTLV-1-associated myelopathy in abou
87 adult T-cell leukemia/lymphoma and tropical spastic paraparesis/HTLV-1-associated myelopathy, among
91 FR deficiency is a rare cause of complicated spastic paraparesis in adults, it should be considered i
92 ssociated myelopathy (also known as tropical spastic paraparesis), infective dermatitis of children a
93 virus type I-associated myelopathy/tropical spastic paraparesis is a chronic progressive inflammator
94 ype 1 (HTLV-1) -associated myelopathy/tropic spastic paraparesis is a demyelinating inflammatory neur
96 identified novel clinical presentations with spastic paraparesis mimicking hereditary spastic paraple
99 t with HTLV-1-associated myelopathy/tropical spastic paraparesis), ongoing infectious spread during c
100 clinical manifestations, including tropical spastic paraparesis or HTLV-1-associated myelopathy (TSP
101 a complicated form of adult-onset hereditary spastic paraparesis partially responsive to betaine ther
102 e of six HTLV-1-associated myelopathy/tropic spastic paraparesis patients carried a significant numbe
103 virus type I-associated myelopathy/tropical spastic paraparesis patients using real-time quantitativ
104 ropic virus I-associated myelopathy/tropical spastic paraparesis, rheumatoid arthritis, multiple scle
107 s with HTLV-I-associated myelopathy/tropical spastic paraparesis suggest that HTLV-I may infect other
108 s with HTLV-1-associated myelopathy/tropical spastic paraparesis than in 29 asymptomatic carriers (80
109 HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP)] and subcortical ischaemic dam
110 d that HTLV-1-associated myelopathy/tropical spastic paraparesis was associated with a lower expressi
111 isease HTLV-1-associated myelopathy/tropical spastic paraparesis was associated with significantly in
112 astic paraplegia (HSP) underlies progressive spastic paraparesis with accompanying ventriculomegaly a
113 sive neurodegenerative subtype of lower limb spastic paraparesis with additional diffuse skin and hai